Stock FBLG FIBROBIOLOGICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company FibroBiologics, Inc.

Equities

FBLG

US31573L1052

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-14 pm EDT 		5-day change 1st Jan Change
11.3 USD +10.35% Intraday chart for FibroBiologics, Inc. +22.56% 0.00%
May. 14 FibroBiologics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 25 FibroBiologics, Inc. Plans to Collaborate with Charles River Laboratories to Manufacture Fibroblast-Based Spheroids CI

Business Summary

FibroBiologics Inc is a United States-based company. The Company operates as a biopharmaceutical company. It is focused on developing and commercializing fibroblast cell-based therapies for patients suffering from chronic diseases. It also develops biologic cures and treatments for chronic diseases, including degenerative disc disease, multiple sclerosis, wound healing, and cancer, and anti-aging extension of life applications such as thymic involution reversal and splenic involution reversal.

Number of employees: 10

Managers

Managers TitleAgeSince
Peter O'Heeron CEO
 Chief Executive Officer 61 21-04-07
Mark Andersen DFI
 Director of Finance/CFO 53 22-05-31
Hamid Khoja CTO
 Chief Tech/Sci/R&D Officer 55 21-07-31

Members of the board

Members of the board TitleAgeSince
Robert Hoffman BRD
 Director/Board Member 58 21-04-07
Richard C. Cilento BRD
 Director/Board Member 61 21-04-07
Peter O'Heeron CEO
 Chief Executive Officer 61 21-04-07
Matthew Link BRD
 Director/Board Member 49 21-04-07
Stacy Coen BRD
 Director/Board Member 53 21-06-30
Victoria Niklas BRD
 Director/Board Member 64 21-04-07

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 32,719,125 22,794,283 ( 69.67 %) 0 69.67 %

Shareholders

NameEquities%Valuation
Peter O'Heeron
18.49 %
6,048,147 18.49 % 71 M $
Richard C. Cilento
0.2849 %
93,225 0.2849 % 1 M $
HRT Financial LLC
0.1753 %
57,344 0.1753 % 669 778 $
Citigroup Global Markets, Inc. (Investment Management)
0.0930 %
30,419 0.0930 % 355 294 $
ExodusPoint Capital Management LP
0.0782 %
25,591 0.0782 % 298 903 $
JPMorgan Securities LLC
0.0692 %
22,634 0.0692 % 264 365 $
NewEdge Advisors LLC
0.0547 %
17,906 0.0547 % 209 142 $
Balyasny Asset Management LP
0.0435 %
14,246 0.0435 % 166 393 $
Geode Capital Management LLC
0.0336 %
10,989 0.0336 % 128 352 $
Matthew Link
0.0229 %
7,500 0.0229 % 87 600 $
NameEquities%Valuation
Peter O'Heeron
100.00 %
2,500 100.00 % 29 200 $

Company contact information

FibroBiologics, Inc.

455 East Medical Center Boulevard Suite 300

77598, Houston

+281 651 5150

http://www.fibrobiologics.com
address FibroBiologics, Inc.(FBLG)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sector Bio Therapeutic Drugs

1st Jan change Capi.
FIBROBIOLOGICS, INC. Stock FibroBiologics, Inc.
0.00% 367M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+5.33% 111B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+12.11% 106B
BIONTECH SE Stock BioNTech SE
-12.56% 22.24B
ARGENX SE Stock argenx SE
-3.55% 21.25B
GENMAB A/S Stock Genmab A/S
-5.99% 18.97B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-35.21% 18.52B
BEIGENE, LTD. Stock BeiGene, Ltd.
-10.86% 16.81B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+37.57% 12.54B
LEGEND BIOTECH CORPORATION Stock Legend Biotech Corporation
-26.24% 8.09B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. FBLG Stock
  4. Company FibroBiologics, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW